IP Library › Granted Patent US 12,030,968
Granted Patent B2
US 12,030,968 · App. 18/096,943 · Granted Jul 9, 2024

Shelf-stable build materials for 3D printing

Inventors: Mehrgan Khavari (Corvallis, OR); Khalil Moussa (Chapel Hill, NC); Scott Broce (Rock Hill, SC)
Assignee: 3D SYSTEMS, INC.
C08F20/36B33Y70/00C09D11/101
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,030,968
App. No.
18/096,943
Granted
Jul 9, 2024
Kind
B2
Abstract

Build materials for 3D printing applications are described herein which, in some embodiments, comprise monomeric species operable for producing articles with high T g and/or high heat deflection temperature while maintaining shelf stability. In one aspect, a polymerizable liquid comprises at least 20 weight percent isocyanurate polyacrylate; a photoinitiator component; and a crystallization inhibitor component comprising monomeric curable material, oligomeric curable material or mixtures thereof, wherein the polymerizable liquid does not exhibit crystallization over a period of 28 days at a storage temperature of 5-10° C.

Claims (24)

1. A polymerizable liquid comprising:

at least 20 weight percent isocyanurate polyacrylate, based on total weight of the polymerizable liquid;

a photoinitiator component; and

a crystallization inhibitor component comprising monomeric curable material,

wherein the monomeric curable material comprises a heterocycle, and

wherein the polymerizable liquid does not exhibit crystallization over a period of 28 days at a storage temperature of 5-10° C.

2. The polymerizable liquid of claim 1 , wherein the isocyanurate polyacrylate is present in an amount of at least 30 weight percent.

3. The polymerizable liquid of claim 1 , wherein the isocyanurate polyacrylate is present in an amount of 30-60 weight percent.

4. The polymerizable liquid of claim 1 , wherein the heterocycle is a polyallylated heterocycle.

5. The polymerizable liquid of claim 4 , wherein the polyallylated heterocycle comprises polyallyl isocyanurate.

6. The polymerizable liquid of claim 5 , wherein the polyallyl isocyanurate is present in an amount of 10-30 weight percent based on total weight of the polymerizable liquid.

7. The polymerizable liquid of claim 5 , wherein a ratio of the isocyanurate polyacrylate to polyallyl isocyanurate is 1:4 to 4:1.

8. The polymerizable liquid of claim 5 , wherein a ratio of the isocyanurate polyacrylate to polyallyl isocyanurate is 1:3 to 3:1.

9. The polymerizable liquid of claim 1 , wherein the monomeric curable material is selected from the groups consisting of aliphatic diacrylates, aliphatic dimethacrylates, cycloalkyl diacrylates, isobornyl acrylate, isobornyl methacrylate, and mixtures thereof.

10. The polymerizable liquid of claim 9 , wherein the monomeric curable material is present in an amount of 10-50 weight percent based on total weight of the polymerizable liquid.

11. The polymerizable liquid of claim 1 , wherein the monomeric curable material is present in an amount of 10-60 weight percent based on total weight of the polymerizable liquid.

12. The polymerizable liquid of claim 1 , wherein the crystallization inhibitor component further comprises an oligomeric curable material, and the oligomeric curable material is present in an amount of 10-40 weight percent based on total weight of the polymerizable liquid.

13. The polymerizable liquid of claim 1 wherein the photoinitiator component is present in an amount of 0.1-5 weight percent based on total weight of the polymerizable liquid.

14. A polymerizable liquid comprising:

at least 20 weight percent isocyanurate polyacrylate, based on total weight of the polymerizable liquid;

a photoinitiator component; and

a crystallization inhibitor component comprising a mixture of monomeric curable material and oligomeric curable material,

wherein the monomeric curable material comprises a heterocycle having two or more unsaturated substituents, and

wherein the polymerizable liquid does not exhibit crystallization over a period of 28 days at a storage temperature of 5-10° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 13, 2023
From: KHAVARI, MEHRGAN; MOUSSA, KHALIL; BROCE, SCOTT
To: 3D SYSTEMS, INC.
Reel/Frame 062374/0442 →
Continuity (3)
Continuation 17060552 · Oct 1, 2020
Provisional Application 62909024 · Oct 1, 2019
Related Publication 20230227590A1 · Jul 20, 2023